NCT03259490View on ClinicalTrials.gov

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

November 13, 2017

Study Completion Date

November 13, 2017

Conditions
Healthy
Interventions
DRUG

Empagliflozin/linagliptin/metformin HCl

Once daily

DRUG

Empagliflozin

Once daily

DRUG

Linagliptin

Once daily

DRUG

Metformin HCl

Once daily

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY

NCT03259490 - This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood | Biotech Hunter | Biotech Hunter